ZyVersa Therapeutics, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q3 2021 to Q4 2022
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
ZyVersa Therapeutics, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q3 2021 to Q4 2022.
- ZyVersa Therapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending December 31, 2022 was 0.21 pure.
- ZyVersa Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)